There is no doubt that the molecular imaging is an extremely important technique in diagnosing diseases. Dual imaging is emerging as a step forward in molecular imaging technique because it can provide us with more information useful for diagnosing diseases than single imaging. Therefore, diverse dual imaging modalities should be developed. Molecular imaging generally relies on imaging agents. Mixed lanthanide oxide nanoparticles could be valuable materials for dual magnetic resonance imaging (MRI)-fluorescent imaging (FI) because they have both excellent and diverse magnetic and fluorescent properties useful for dual MRI-FI, depending on lanthanide ions used. Since they are mixed nanoparticles, they are compact, robust, and stable, which is extremely useful for biomedical applications. They can be also easily synthesized with facile composition control. In this study, we explored three systems of ultrasmall mixed lanthanide (Dy/Eu, Ho/Eu, and Ho/Tb) oxide nanoparticles to demonstrate their usefulness as dual T 2 MRI-FI agents.
There is no doubt that the molecular imaging is an extremely important technique in diagnosing diseases. Dual imaging is emerging as a step forward in molecular imaging technique because it can provide us with more information useful for diagnosing diseases than single imaging. Therefore, diverse dual imaging modalities should be developed. Molecular imaging generally relies on imaging agents. Mixed lanthanide oxide nanoparticles could be valuable materials for dual magnetic resonance imaging (MRI)-fluorescent imaging (FI) because they have both excellent and diverse magnetic and fluorescent properties useful for dual MRI-FI, depending on lanthanide ions used. Since they are mixed nanoparticles, they are compact, robust, and stable, which is extremely useful for biomedical applications. They can be also easily synthesized with facile composition control. In this study, we explored three systems of ultrasmall mixed lanthanide (Dy/Eu, Ho/Eu, and Ho/Tb) oxide nanoparticles to demonstrate their usefulness as dual T 2 MRI-FI agents.
T
here is a continuing research interest in mixed lanthanide oxide nanoparticles because they have both magnetic and fluorescent properties useful for dual imaging in biomedicine [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . By using different lanthanide ions in synthesis, a variety of mixed lanthanide oxide nanoparticles can be synthesized. These mixed nanoparticles generally have an advantage over core-shell 11 , hetero-junction 12 , and dye-coated nanoparticles 13 because of their compactness, robustness, stability, and easy synthesis with composition control. In addition, several inherent magnetic and fluorescent properties of mixed lanthanide oxide nanoparticles are valuable in molecular imaging. First, their magnetic and fluorescent properties are not much affected by surface coating due to compactness of 4f-orbitals close to nucleus 14 . Second, their magnetic properties do not change much with particle diameter for the same reason 14 . Third, their fluorescent intensities enhance with decreasing particle diameter due to reduced excitation migration to quenching sites that are proportional to particle diameter 15, 16 . Therefore, ultrasmall mixed lanthanide oxide nanoparticles will be extremely useful for dual magnetic resonance imaging (MRI)-fluorescent imaging (FI), as demonstrated in this study.
There is no doubt that dual imaging will play a vital role in diagnosing diseases in the near future. First, dual imaging can generally provide more information useful for diagnosing diseases than the single imaging does 17, 18 . Injection doses can be reduced because a single dose of a dual imaging agent will cover both doses of single imaging agents. Regarding MRI-FI, MRI generally has a high spatial resolution of , 1 mm while FI, a very high sensitivity that is limited by that of an optical device 19, 20 . Therefore, a dual MRI-FI modality will allow us to detect and diagnose diseases very sensitively and in a high spatial resolution 21 . This study deals with T 2 MRI-FI agents. While FI entirely relies on chemical agents, MRI is greatly improved using contrast agents through contrast enhancements. Here, it is worth to mention that a good MRI contrast agent should satisfy that it should be non-toxic, completely excreted from a body through renal system after some time after intravenous injection, should have a large r 1 value and r 2 /r 1 ratio close to one in case of a T 1 MRI contrast agent, and a large r 2 value in case of a T 2 MRI contrast agent to show high contrast MR images at a standard injection dose. T 2 MRI contrast agents can be made by nanoparticles but not by molecules because large magnetic moments at room temperature are needed in accelerating transverse water proton relaxation that is induced by fluctuation of local magnetic field generated by nanoparticles [22] [23] [24] . Although lanthanide oxide nanoparticles have only decent magnetic moments at room temperature, they are useful at high MR fields 25, 26 . Their magnetic moments are decent even at ultrasmall particle diameters, extremely useful for in vivo applications because only ultrasmall nanoparticles can be excreted through renal system 27 . They can also have diverse fluorescent colours, depending on lanthanide elements 14, 28, 29 . Their fluorescent properties are similar to quantum dots (QDs) except for their weaker fluorescent intensities. That is, they have narrow band widths useful for multiplex imaging and high photostabilities like QDs 30, 31 , which are superior to dyes because dyes have wide band widths 32 and poor photostabilities (i.e., subject to photobleaching and photodecomposition after multiple uses) 28 . Lower fluorescent intensities of lanthanide oxide nanoparticles than those of QDs and dyes can be partly overcome through the imaging depth increase using upconversion compositions [33] [34] [35] . As summarized in Table 1 , Dy, Ho, and Tb have large magnetic moments 14 while Eu and Tb strongly fluoresce in visible region 14, 28, 29 . Although not listed in Table 1 , Gd and Er also have large magnetic moments comparable to those of the above three elements 14 . Therefore, ultrasmall mixed lanthanide oxide nanoparticles composed of these elements will be useful for both MRI and FI. Their basic applications to biomedical imagings are schematically represented in Fig. 1 . In this study, we explored three systems of ultrasmall mixed lanthanide (Dy/Eu, Ho/Eu, and Ho/Tb) oxide nanoparticles to demonstrate their usefulness as T 2 MRI-FI agents by investigating their in vivo T 2 MR images and in vitro fluorescent confocal images.
Results
Composition, particle diameter, and hydrodynamic diameter. Compositions in Dy x Eu y O 3 , Ho x Eu y O 3 , and Ho x Tb y O 3 nanoparticles were estimated to be (x, y) 5 (1.5 6 0.1, 0.5 6 0.1), (1.6 6 0.1, 0.4 6 0.1), and (1.1 6 0.1, 0.9 6 0.1), respectively, using an inductively coupled plasma atomic emission spectrometer (ICPAES). x and y values were similar to precursor ion molar ratios used in synthesis within an experimental error limit, implying that reaction properties of all lanthanide ions are similar to one another likely due to their identical trivalent ionic state and similar ionic radii. Therefore, composition can be easily controlled just by varying precursor ion molar ratios.
Particle diameters were estimated using two electron microscopes (EMs) with different acceleration voltages. D-glucuronic acid coated nanoparticles are hydrophilic because they are coated with hydrophilic D-glucuronic acids and thus were not monodispersed but mostly aggregated in EM images because they were dispersed on hydrophobic carbon film on copper grid. This is opposite to hydrophobic nanoparticles synthesized in organic solvents that can be monodispersed on carbon film 36, 37 . From high resolution transmission electron microscope (HRTEM) and high voltage electron microscope (HVEM) images in Fig. 2A 38 may not be observed in the present mixed nanoparticles. This is because of similar ionic radii and similar reaction properties between lanthanide ions.
From dynamic light scattering (DLS) patterns in Fig. 2D , the average hydrodynamic diameters (a avg s) of D-glucuronic acid coated ultrasmall Dy 1.5 Eu 0.5 O 3 , Ho 1.6 Eu 0.4 O 3 , and Ho 1.1 Tb 0.9 O 3 nanoparticles were estimated to be 6.7 6 0.1, 6.4 6 0.1, and 7.6 6 0.1 nm, respectively. Pictures of well-dispersed aqueous sample solutions are also inserted in Fig. 2D . We also investigated crystal structures of powder samples of D-glucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles by measuring X-ray diffraction (XRD) patterns (Supplementary data). As-prepared powder samples showed very broad patterns as observed in unmixed nanoparticles 39 whereas powder samples after thermal treatment with a thermogravimetric analyzer (TGA) showed sharp peaks, all corresponding to a highly crystallized cubic Ln 2 O 3 due to particle size growth during TGA treatment 25, 39 .
Surface coating. Nanoparticles should be coated with water-soluble and biocompatible ligands for biomedical applications. D-glucuronic acid was used in this study. The surface coating was investigated by recording Fourier transform-infrared (FT-IR) absorption spectra of powder samples of D-glucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles in pallet forms in KBr as shown in Fig. 3A . A FT-IR absorption spectrum of a free D-glucuronic acid was also recorded as a reference as shown in Fig. 3A . Stretching ) of a free Dglucuronic acid, confirming that its -COOH group was bonded to a nanoparticle. This red shift has been observed in various metal oxide nanoparticles coated with ligands with -COOH group [39] [40] [41] [42] [43] , supporting our results. TGA curves were also recorded to estimate the amount of surface coating with D-glucuronic acid as shown in oersted (Oe) (Fig. 4B) . Here, magnetizations in Fig. 4 corresponded to net magnetizations of ultrasmall mixed lanthanide oxide nanoparticles in powder samples because they were mass-corrected with net masses of nanoparticles in powder samples as described in experimental section. Both coercivities and remanences in M-H curves were zero (i.e., no hysteresis). This lack of hysteresis and no magnetic transition down to T 5 5 K in all M-T curves showed that all ultrasmall mixed lanthanide oxide nanoparticles were paramagnetic down to 5 K, consistent with previous reports [45] [46] [47] [48] . Table 1 ). Net magnetizations of ultrasmall mixed lanthanide oxide nanoparticles estimated from M-H curves at T 5 5 and 300 K were plotted in Fig. 4C . As shown in Fig. 4C , net magnetizations at T 5 300 K are decent due to unsaturated magnetizations at room temperature, whereas those at T 5 5 K are large due to nearly saturated magnetizations. Magnetizations at room temperature are important for water proton relaxation because the water proton relaxivity (r) is proportional to the square of magnetization [22] [23] [24] and thus, should be as large as possible. . Note that only a pure electron spin magnetic moment as in Gd 31 can strongly induce a longitudinal water proton relaxation 22, 23 . In fact, gadolinium oxide and gadoliniumbased nanoparticles have shown very large r 1 values [49] [50] [51] [52] . However, r 2 values, depending on total magnetic moment of contrast agents were decent in all samples because of decent magnetizations of nanoparticles at room temperature. As expected, r 1 and r 2 values were comparable to those of unmixed lanthanide oxide nanoparticles 25, [53] [54] [55] [56] . Both r 1 and r 2 values became reduced when they were estimated from combined concentration plots as shown in Fig. 5C , a lot smaller magnetic moment than both Dy 31 and Ho 31 (see Table 1 ). As expected from negligible r 1 and decent r 2 values, negligible dose-dependent contrast enhancements in R 1 map images and appreciable dose-dependent contrast enhancements in R 2 map images were observed in all samples as shown in Fig. 5D . These results suggest that the present ultrasmall mixed lanthanide oxide nanoparticles are potential T 2 MRI contrast agents at high MR fields because their r 2 values and therefore their contrast enhancements in R 2 map images will further increase with MR field because r 2 is proportional to the square of MR field as mentioned before [22] [23] [24] . It will be valuable to compare r 1 and r 2 values of the present nanoparticles with those of other nanoparticles at similar particle diameters. As shown in Fig. 5E . The present nanoparticles, however, showed negligible r 1 values because Dy 31 , Ho 31 , and Tb 31 have both electron orbital (L) and spin (S) magnetic moments as mentioned before, but the largest r 2 values due to their decent magnetic moments at room temperature. Therefore, as T 2 MRI contrast agents, the present nanoparticles are superior to other nanoparticles at ultrasmall particle diameters. This is important because ultrasmall nanoparticles are useful for in vivo applications because they can be excreted through renal system 27 
.
Fluorescent properties. Fluorescent properties of D-glucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles in ethanol were investigated by recording photoluminescent (PL) spectra as shown in Fig. 6 . PL spectra of precursor ions in ethanol were also recorded as references as shown in Fig. 6 . We observed constant emission intensities and identical PL spectra for repeated measurements, supporting good photostabilities of these nanoparticles.
As shown in Table 1 and Fig. 6 , the main fluorescent lanthanide ions in sample solutions were Eu 31 and Tb
31
. The other ions negligibly contributed to PL spectra. Therefore, it was expected that PL spectra of sample solutions would resemble those of Eu 31 or Tb 31 precursor ions. However, PL spectra of sample solutions were quite different from those of these ions in two respects. First, PL spectra of sample solutions were generally broad. Second, new peaks (assigned as ''*'') appeared with position and/or intensity quite different from those of precursor ions. 62 . Possibilities for these include the energy level coupling between emitting and other elements in nanoparticles 60 , some disorder in nanoparticles (i.e., size effect) 61, 62 , and luminescence of surface elements in nanoparticles 61, 62 . Fluorescent sample solutions in ethanol after irradiation with a mercury lamp are inserted at the top in Fig. 6 64, 65 , but slightly higher likely due to their ultrasmall particle diameters because it was found that fluorescent intensity of lanthanide oxide nanoparticles become enhanced with decreasing particle diameter 15, 16 .
In vitro cytotoxicity results. The toxicities of three aqueous sample solutions of D-glucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles were investigated by measuring cytotoxicity up to 400 (or 500) mM combined concentrations using both DU145 and NCTC1469 cells as shown in Fig. 7 . They were non-toxic and thus, used for in vivo MR experiments. In vivo 3 tesla T 2 MR images. To measure in vivo 3 tesla T 2 MR images, aqueous sample solutions of D-glucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles were injected into a mouse tail vein. As shown in Fig. 8 , decent negative contrast enhancements in both liver and kidneys were observed one hour after intravenous injection. Therefore, D-glucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles clearly functioned as T 2 MRI contrast agents. Stronger negative contrast enhancements will be observed at higher MR fields because r 2 is proportional to the square of applied MR field as mentioned before [22] [23] [24] , implying that these nanoparticles are potential T 2 MRI contrast agents at high MR fields. Furthermore, antibodies, peptides or targeting molecules will increase the targeting ability of nanoparticles and as a result, provide the improved contrasts in MR images. More 3 tesla T 2 MR images in a mouse are provided in Supplementary data.
In vitro fluorescent confocal cellular images. To measure in vitro fluorescent confocal cellular images, aqueous sample solutions were treated to DU145 cells. Control DU145 cells to which no sample solution was treated were also prepared in the same condition. As shown at the top images in Figs. 9A to C, cell nuclei tinted pale blue at l ex 5 405 nm because they were stained with 49,6 diamidino-2-phenylindole (DAPI). As shown at the bottom image in 
Discussion
In this study we demonstrated that ultrasmall mixed lanthanide oxide nanoparticles had excellent dual imaging properties. We used three systems of ultrasmall mixed lanthanide (Dy/Eu, Ho/Eu, and Ho/Tb) oxide nanoparticles to demonstrate this. The three main findings are following: (1) ultrasmall mixed lanthanide oxide nanoparticles are compact, robust, and stable, which is extremely useful for biomedical applications. They can be also easily synthesized with composition control. (2) They showed decent magnetizations at room temperature and as a result, appreciable r 2 values. Decent negative contrast enhancements in 3 tesla T 2 MR images in a mouse were observed, clearly demonstrating their capability as T 2 MRI contrast agents. Since r 2 is proportional to the square of MR field, these nanoparticles will be extremely useful as T 2 MRI contrast agents at high MR fields. (3) They strongly showed fluorescent confocal images in DU145 cells, clearly demonstrating their capability as FI agents. Therefore, ultrasmall mixed lanthanide oxide nanoparticles are potential dual T 2 MRI-FI agents that will be extremely useful for biomedical applications. It is worth to mention that although not studied here, we expect that ultrasmall mixed Dy/Tb oxide nanoparticles will give similar results as those of the above three nano-systems studied in this work.
Mixed lanthanide oxide nanoparticles are extremely valuable for in vivo applications because they are compact, robust, and stable as mentioned above. This is critical because after intravenous injection they should not be decomposed and their properties should not be changed. As mentioned before, their magnetic properties do not much depend on surface coating and particle diameter due to compactness of 4f-orbitals close to nucleus 14 and their fluorescent intensities rather enhance with decreasing particle diameter due to reduced excitation migration to quenching sites that are proportional to particle diameter 15, 16 , implying that they can be made ultrasmall without degrading their magnetic and fluorescent properties. Note that ultrasmall nanoparticles can be excreted through renal system 27 , which is pre-requisite to in vivo applications. Therefore, ultrasmall mixed lanthanide oxide nanoparticles will be extremely useful for MRI-FI dual agents, as demonstrated in this study. For instance, a dual MRI-FI modality will allow us to detect and diagnose diseases very sensitively through FI and in a high spatial resolution through MRI.
In summary, we synthesized ultrasmall mixed lanthanide (Ln) oxide nanoparticles in which one Ln is used for MR imaging and the other Ln, for fluorescent imaging. We explored three systems (Dy/Eu, Ho/Eu, and Ho/Tb) in which Dy, Ho, and Tb are used for MR imaging and Eu and Tb, for fluorescent imaging. They clearly showed negative contrast in 3 tesla T 2 MR images in a mouse and a very intense fluorescence in confocal images in DU145 cells, demonstrating their usefulness as MRI-FI dual agents.
Methods
Chemicals. Dy(NO) 3 .xH 2 O (99.9%), Ho(NO 3 ) 3 .5H 2 O (99.9%), Eu(NO 3 ) 3 .5H 2 O (99.9%), Tb(NO 3 ) 3 .5H 2 O (99.9%), NaOH (. 99.9%), 50% H 2 O 2 aqueous solution, triethylene glycol (99%), CH 3 OH (99.9%), and D-glucuronic acid (99.99%) were purchased from Sigma-Aldrich and used as received. C 2 H 5 OH (99%) was purchased from Duksan (S. Korea) and used as received in washing nanoparticles. Triply distilled water was used for both washing nanoparticles and preparing sample solutions.
One-pot synthesis of D-glucuronic acid coated ultrasmall mixed Dy/Eu, Ho/Eu, and Ho/Tb oxide nanoparticles. 4 mmol of Dy(NO 3 ) 3 .xH 2 O (or Ho(NO 3 ) 3 .5H 2 O) and 1 mmol of Eu(NO 3 ) 3 .5H 2 O were added to 40 mL of triethylene glycol in a 100 mL three neck flask. The mixture solution was magnetically stirred at 40uC under atmospheric condition until the precursor salts were completely dissolved in triethylene glycol. In a separate flask, NaOH solution was prepared by dissolving 15 mmol of NaOH in 5 mL of methanol. Then NaOH solution was slowly added to the above precursor solution using a syringe. The reaction temperature was raised to 240uC and maintained at that temperature for 24 hours with magnetic stirring. The product nanoparticle solution was cooled to 80uC for surface coating. In case of mixed Ho/Tb oxide nanoparticles, 2.5 mmol of Ho(NO 3 ) 3 .5H 2 O and 2.5 mmol of Tb(NO 3 ) 3 .5H 2 O were added to 40 mL of triethylene glycol. The mixture solution was magnetically stirred until the precursor salts were completely dissolved in triethylene glycol. The NaOH solution prepared in 5 mL of methanol in a separate flask was slowly added to the above precursor solution using a syringe. The mixture solution was magnetically stirred at 80uC for 2 hours. Then 7.5 mL of 50% H 2 O 2 aqueous solution was slowly added to the reaction solution using a syringe. After addition of H 2 O 2 , the reaction mixture was magnetically stirred for additional 2 hours.
For surface coating, 5 mmol of D-glucuronic acid was added to the above nanoparticle solutions that were magnetically stirred at 80uC for 24 hours under atmospheric condition. The product solutions were cooled to room temperature and transferred to 1 L beakers containing 500 mL of triply distilled water (or ethanol) to wash product nanoparticles. After nanoparticles settled to the beaker bottom, top transparent solutions were decanted and the remaining nanoparticles were washed again with triply distilled water (or ethanol) for three times. When ethanol was used as a washing solvent, nanoparticles were washed again with triply distilled water to remove ethanol. The first half volumes of washed nanoparticles were diluted with triply distilled water to prepare aqueous sample solutions and the remaining half volumes were reduced to powder form by drying them in air for various characterizations.
Characterizations. An ICPAES (Thermo Jarrell Ash Co., IRIS/AP) was used to measure the concentration of Ln (Ln 5 Dy, Ho, Eu, and Tb) in aqueous sample solutions. Ultrasmall particle diameters were estimated using a HRTEM (JEOL, JEM 2100F, 200 kV acceleration voltage) and a HVEM (JEOL JEM-ARM 1300 S, 1.2 MeV acceleration voltage). A copper grid (PELCO No.160, TED PELLA, INC.) covered with an amorphous carbon membrane was placed onto a filter paper and a nanoparticle solution diluted in triply distilled water or ethanol was dropped over the copper grid using a micropipette (Eppendorf, 2-20 mL). A DLS particle size analyzer (UPA-150, Microtrac) was used to measure the hydrodynamic diameters of Dglucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles dispersed in triply distilled water. The sample solution concentration used to measure hydrodynamic diameters was , 0.1 mM Ln (Ln 5 Dy, Ho, Eu or Tb). An XRD spectrometer (Philips, X'PERT PRO MRD) with an unfiltered CuKa radiation (l 5 1.54184 Å ) was used to measure the crystal structure of powder samples of Dglucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles. The scanning step was 0.033u and scan range in 2h was 15-100u. A FT-IR absorption spectrometer (Mattson Instruments, Inc., Galaxy 7020A) was used to investigate the surface coating in ultrasmall mixed lanthanide oxide nanoparticles. To record FT-IR absorption spectra (400-4000 cm 21 ), pellets of powder samples in KBr were prepared. A TGA (TA Instruments, SDT-Q 600) was used to estimate the amount of surface coating with D-glucuronic acid in powder samples from the mass drop in TGA curves. TGA curves were recorded between room temperature and 900uC while air flowed. A superconducting quantum interference device (SQUID) magnetometer (Quantum Design, MPMS-7) was used to measure the magnetic properties of ultrasmall mixed lanthanide oxide nanoparticles. Both M-H curves (25 # H # 5 tesla) at T 5 5 and 300 K and ZFC M-T curves (5 # T # 300 K) at H 5 0 or 100 Oe were recorded. To measure both M-H and M-T curves, weighed powder samples were loaded into nonmagnetic gelatine capsules. To obtain net magnetizations of ultrasmall mixed lanthanide oxide nanoparticles in powder samples, observed magnetizations were mass-corrected using both powder sample masses and weight percents of ultrasmall mixed lanthanide oxide nanoparticles in powder samples estimated from TGA curves. A PL spectrometer (JASCO, FP-6500) was used to record PL spectra of D-glucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles dispersed in ethanol at l ex 5 220 nm. The PL spectra of all precursor Ln 31 (Ln 5 Dy, Ho, Eu, and Tb) ions in ethanol were also recorded as references. Sample solution and precursor ion concentrations used to measure PL spectra were , 10 mM Ln (Ln 5 Eu or Tb). Sample solutions were filled into a quartz cuvette with four optically clear sides (Sigma-Aldrich, 3 mL) for PL measurement. Quantum yields (Ws) of sample solutions (1.0 mM in ethanol) were roughly estimated using fluorescein as a standard (W 5 0.95, 1.0 mM in 0.1 M NaOH ethanol solution) 63 at l ex 5 220 nm. We used an equation of W (sample) < W (fluorescein) 3 PL Intensity (sample)/PL Intensity (fluorescein) to estimate the Ws of the sample solutions.
In vitro cytotoxicity measurement. A CellTiter-Glo Luminescent Cell Viability Assay (Promega, WI, USA) was used to measure the cellular toxicity of aqueous sample solutions of D-glucuronic acid coated ultrasmall mixed lanthanide oxide nanoparticles. In this assay, a luminometer (Victor 3, Perkin-Elmer) was used to quantify the intracellular adenosine triphosphate (ATP). Both human prostate cancer (DU145) and normal mouse hepatocyte (NCTC1469) cells were used as test cells. DMEM and RPMI1640 were used as culture media for NCTC1469 and DU145 cells, respectively. Cells were seeded on a 24-well cell culture plate and incubated for 24 hours (5 3 10 4 cell density, 500 mL cells per well, 5% CO 2 , and 37uC). Test sample solutions (10, 50, 100, 200, 400, 500 mM Ln 1 &Ln 2 ) (Ln 1 5 Dy or Ho, Ln 2 5 Eu or Tb) were prepared by diluting original sample solutions with a sterile phosphate-buffered saline (PBS) solution. Then, , 2 mL of each test sample solution was treated into the cultured cells, which were further incubated for 48 hours. Cell viability was measured and normalized with respect to the control cell with 0.0 M Ln concentration. The measurement was repeated twice for all sample cells to obtain average cell viabilities.
Relaxivity and map image measurement. A 1.5 tesla MRI instrument (GE 1.5 T Signa Advantage, GE medical system) equipped with the knee coil (EXTREM) was used to measure both T 1 and T 2 relaxation times as well as both R 1 and R 2 map images. A series of aqueous sample solutions with different concentrations (1, 0.5, 0.25, 0.125, 0.0625, and 0 mM Ln (Ln 5 Dy or Ho)) were prepared by diluting original sample solutions with triply distilled water. Both relaxation times and map images were measured for these solutions. The r 1 and r 2 water proton relaxivities were then estimated from the slopes in the plots of 1/T 1 and 1/T 2 versus Ln (Ln 5 Dy or Ho) or combined Ln 1 &Ln 2 (Ln 1 5 Dy or Ho, Ln 2 5 Eu or Tb) concentrations, respectively. The typical measurement parameters were as follows: the external MR field (H) 5 1.5 tesla, the temperature (T) 5 22uC, the number of acquisition (NEX) 5 1, the field of view (FOV) 5 16 cm, the phase FOV 5 1 cm, the matrix size 5 512 3 512, the slice thickness 5 5 mm, the spacing gap 5 0 mm, the pixel bandwidth 5 61.0547, the time of repetition (TR) 5 2009 ms, and the time to echo (TE) 5 9 ms.
In vivo 3 tesla T 2 MR image measurement. The animal experiments using mice in this study were approved by the animal research committee of Kyungpook National University (KNU) and carried out in accordance with its the rule. A 3 tesla MRI instrument (SIEMENS 3.0 T MAGNETOM Trio a Tim) was used to measure T 2 spin echo (SE) images of a mouse. An ICR female mouse with weight of , 30 g was used for each sample solution. Each mouse was anesthetized by 1.5% isoflurane in oxygen. Measurements were made before and after injection of a sample solution into a mouse tail vein. The injection dose was , 30 mL and , 0.05 mmol Ln 1 &Ln 2 /kg (Ln 1 5 Dy or Ho, Ln 2 5 Eu or Tb). After measurement, a mouse was revived from anaesthesia and placed in a cage with a free access to both food and water. During measurement, each mouse was maintained at , 37uC by using a warm water blanket. The typical measurement parameters were as follows: (coronal view) H 5 3 tesla, T 5 37uC, NEX 5 3-4, FOV 5 60 mm, the phase FOV 5 60 mm, the matrix size 5 256 3 256, the slice thickness 5 1 mm, the spacing gap 5 0.1 mm, TR 5 1620 ms, and TE 5 37 ms; (axial view) H 5 3 tesla, T 5 37uC, NEX 5 3-4, FOV 5 60 mm, the phase FOV 5 30 mm, the matrix size 5 128 3 256, the slice thickness 5 1 mm, the spacing gap 5 0.1 mm, TR 5 2690 ms, and TE 5 37 ms.
In vitro fluorescent confocal cellular image measurement. A confocal laser scanning microscope (Carl Zeiss, LSM 700) equipped with a solid state laser was used to measure fluorescent images of DU145 cells. The DU145 cells were seeded onto two 35 mm cell culture dishes at the density of 2.5 3 10 5 per dish (2 mL, 5% CO 2 , 37uC). After 24 hours, one of the above two cell dishes was treated with , 50 mL of an aqueous sample solution (0.2-0.3 mM Eu or Tb) and incubated for 48 hours. The treated cells were washed with PBS solution twice. The untreated cells in the other dish served as control cells. The cells in both dishes were fixed with 4% paraformaldehyde (PFA) in PBS solution for 10 minutes at room temperature. After this, the cells in both dishes were washed again with PBS solution 3 times. The cell nuclei in both dishes were then stained with DAPI and washed again with PBS solution 3 times. The cells were mounted using Prolong Gold (Invitrogen, Carlsbad, CA, USA) for imaging. The laser power used for excitation was , 8 watts. The l ex s used for excitation of DAPI and nanoparticles were 405 and 488 nm, respectively. At l ex 5 405 nm, DAPI tinted pale blue. The typical magnifications used for imaging were 400 and 1000.
